Novagali Pharma SA
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Novagali Pharma SA
This week's roundup includes a new CEO for Oxeia, in addition to various other high-level appointments by Piramal Pharma Solutions, Bone Therapeutics, Kiadis and biOasis. Artios Pharma also welcomes AstraZeneca's former senior director bioscience, oncology to its team.
Plus news on recent financial activity by Mersana Therapeutics, Hyperion Therapeutics, Atterocor and Exelixis.
Plus news on recent financings by Genkyotex, Synageva, Nektar Therapeutics and Edmond de Rothschild Investment Partners.
Four years after closing the BioDiscovery 3 at €156 million, Edmond de Rothschild Investment Partners is now on the road raising a €200 million fourth fund to invest innovative European life sciences companies. The French venture capitalist started fundraising three weeks ago and is confident that it will be able to complete a first closing at more than €100 million by the end of April or early May.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.